Breaking News

Synerlab Acquires Lyofal

November 15, 2012

Gains lyophilization services

Synerlab, a French CMO, has acquired Lyofal, gaining access to the growing market of lyophilized dosage forms, and expanding its existing range of outsourcing services. Financial terms of the acquisition were not disclosed.
Lyofal’s core business is outsourcing lyophilization services, providing services from determining lyophilization parameters, formulation assistance, and improvement of existing cycles within R&D, to production of pilot and industrial scale for bulk products (APIs, plant or animal extracts), as well as vials (diagnostic use) or molded forms (haemostatic patches or medical devices).

Related Contract Manufacturing:

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks